Clinical Trial Update: Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating pretreatment staging of high-risk prostate cancer using 18F-Fluciclovine PET/MRI across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-22